Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07844070

A Study of Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy

Sponsor: Novartis Pharmaceuticals

View on ClinicalTrials.gov

Summary

This study aims to assess the real-world patterns of disease modifying therapy (DMT) use before, during, and after pregnancy in women with multiple sclerosis (MS). The study will use a pooled closed claims database containing closed payer medical and pharmacy claims data for patients in the United States (US).

Official title: Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy

Key Details

Gender

FEMALE

Age Range

18 Years - 49 Years

Study Type

OBSERVATIONAL

Enrollment

2607

Start Date

2026-03-06

Completion Date

2026-10-30

Last Updated

2026-09-28

Healthy Volunteers

No

Locations (1)

Novartis

East Hanover, New Jersey, United States